Organogenesis Holdings Inc.

Avista Healthcare Public Acquisition Corp (Nasdaq: AHPA), sponsored by Avista Capital Partners, was a healthcare-sector blank-check company that completed its initial public offering in 2016. The vehicle filed an 8-K with the SEC on October 14, 2016, an early post-IPO disclosure as the SPAC pursued a target in the healthcare and life sciences industry. The SPAC ultimately completed its business combination with Organogenesis, a regenerative medicine company, in December 2018, with the surviving public entity rebranded as Organogenesis Holdings Inc. and trading on Nasdaq under the ticker ORGO. Sign up at SpacDesk for full filing histories, sponsor profiles, and deal analytics across the SPAC universe.